Approval for an increase in membrane length and an increase inhousing length of the heparin adsorber. the device, as modified, will be marketed under the trade name heparin adsorber 400 and is indicated for use as a component of the h. e. l. p futura apheresis system, used for the removal, by ionic exchange, of excess heparin added to precipitate lipoproteins from plasma.